CD14 and ganglioneuroma: Biomarkers such as PCT, lipopolysaccharide-binding protein, the CD14-ST isoform and the interleukin-6 measurement are described as potential biomarkers to distinguish BSI-GN, however, these data are inconsistent, since some studies obtained promising results with PCT1,12,33,34.